No long-term evidence of hyporesponsiveness following the use of pneumococcal conjugate vaccine in children previously immunised with pneumococcal polysaccharide vaccine

BACKGROUND: A randomised controlled trial in Fiji examined the immunogenicity and impact on nasopharyngeal carriage following 0, 1, 2 or 3 doses of pneumococcal conjugate vaccine (PCV7) in infancy followed by 23-valent pneumococcal polysaccharide (23vPPV) vaccine at 12 months of age. At 18 months of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Allergy Clin Immunol
Autors principals: Licciardi, Paul V, Toh, Zheng Quan, Clutterbuck, Elizabeth A, Balloch, Anne, Marimla, Rachel A, Tikkanen, Leena, Lamb, Karen E, Bright, Kathryn J, Rabuatoka, Uraia, Tikoduadua, Lisi, Boelsen, Laura K, Dunne, Eileen M, Satzke, Catherine, Cheung, Yin Bun, Pollard, Andrew J, Russell, Fiona M, Mulholland, Edward K
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899320/
https://ncbi.nlm.nih.gov/pubmed/26825000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.12.1303
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars